Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00577395 · ClinicalTrials.gov registry record · Phase 4
Bone Microarchitecture in Osteopenic Postmenopausal Women
A Phase 4 study, sponsored by Warner Chilcott.
- Terminated
- Registry status
- Phase 4
- Development phase
- 13
- Enrollment target
NCT00577395 is a Phase 4 study that was terminated before completion, run by Warner Chilcott. The registered enrollment target is 13 participants.
The verdict
NCT00577395, a Phase 4 study, was terminated before completion, sponsored by Warner Chilcott.
- TERMINATED
- Registry status
- Phase 4
- Development phase
- 13 participants
- Enrollment target
Study Summary
The purpose of this trial is to compare the difference in bone microarchitecture of the distal radius at month 12 in postmenopausal osteopenic women treated with risedronate 150mg taken once a month compared to placebo.
Interventions
- DRUG placebo
- DRUG risedronate
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 13 participants |
| Start Date | 2008-07 |
| Est. Completion | 2009-02 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00577395
The ClinicalTrials.gov registry entry for NCT00577395 describes a study currently listed as terminated, categorized as Phase 4. The registered enrollment target is 13 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Warner Chilcott, which has 53 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which placebo is the first listed.
NCT00577395 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00577395 about?
NCT00577395 is a clinical study titled "Bone Microarchitecture in Osteopenic Postmenopausal Women". The purpose of this trial is to compare the difference in bone microarchitecture of the distal radius at month 12 in postmenopausal osteopenic women treated with risedronate 150mg taken once a month compared to placebo.
What is the current status of trial NCT00577395?
This trial is currently terminated. It is a Phase 4 study. The enrollment target is 13 participants. The study started on 2008-07. Estimated completion is 2009-02.
What interventions are being tested in trial NCT00577395?
The interventions under investigation include: placebo (DRUG), risedronate (DRUG).
Who is sponsoring clinical trial NCT00577395?
This trial is sponsored by Warner Chilcott, which has 53 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.